PharmEasy In Early Funding Talks With SoftBank

SoftBank Group is in early-stage talks to invest nearly $100 million in online pharma startup PharmEasy, reports. Citing sources, it says that the company is eyeing a valuation of $400 million in this funding round. PharmEasy had earlier raised $50 million funding in a round led by Eight Roads Ventures India, the proprietary investment arm of FIL (Fidelity International Limited), F-Prime Capital, Nandan Nilekani, and Sanjeev Aggarwal which is also is backed Fundamentum Partnership and San Francisco based hedge fund Think Investments. The company was valued at $150 million posts this round, the report had reported in September last year.